{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:37:25Z","timestamp":1789663045703,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K99HL179392"],"award-info":[{"award-number":["K99HL179392"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK132549"],"award-info":[{"award-number":["R01DK132549"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["K00CA245728"],"award-info":[{"award-number":["K00CA245728"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["PO1CA049605"],"award-info":[{"award-number":["PO1CA049605"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.coi.2025.102685","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:03:07Z","timestamp":1761843787000},"page":"102685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Regulatory T cell approaches for graft-versus-host disease prevention"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-0113","authenticated-orcid":false,"given":"Cameron S","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett H","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102685_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102685_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565518","article-title":"The next frontier of regulatory T cells: promising immunotherapy for autoimmune diseases and organ transplantations","volume":"11","author":"Terry","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib4","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease \u2014 biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102685_bib5","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102685_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/stmcls\/sxaf009","article-title":"Cellular therapies for the prevention and treatment of acute graft-versus-host disease","volume":"43","author":"Peltier","year":"2025","journal-title":"Stem Cells"},{"key":"10.1016\/j.coi.2025.102685_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.coi.2025.102685_bib8","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102685_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41409-022-01908-y","article-title":"Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.coi.2025.102685_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102685_bib11","article-title":"Cytolytic CD4","volume":"13","author":"Bolivar-Wagers","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2025.102685_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.02.015","article-title":"Regulatory T cell amelioration of graft-versus-host disease following allogeneic\/xenogeneic hematopoietic stem cell transplantation using mobilized mouse and human peripheral blood donors","volume":"29","author":"Barreras","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.coi.2025.102685_bib14","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","article-title":"L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection","volume":"104","author":"Taylor","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib15","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","article-title":"Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD","volume":"105","author":"Ermann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_sbref16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47575-z","article-title":"Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease","volume":"15","author":"Dittmar","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102685_bib17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.2022017982","article-title":"Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD","volume":"141","author":"Lohmeyer","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41375-023-01932-x","article-title":"A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect","volume":"37","author":"Guardalupi","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.coi.2025.102685_bib19","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","article-title":"CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines","volume":"121","author":"Pesenacker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_sbref20","article-title":"Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD","volume":"4","author":"Jarosch","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coi.2025.102685_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179458","article-title":"Human gut microbiota-reactive DP8\u03b1 Tregs prevent acute graft-versus-host disease in a CD73-dependent manner","volume":"9","author":"Godefroy","year":"2024","journal-title":"JCI Insight"},{"issue":"Suppl 2","key":"10.1016\/j.coi.2025.102685_bib22","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0405234101","article-title":"Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells","volume":"101","author":"Bluestone","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102685_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011726","article-title":"Human antigen-specific regulatory T cells generated by T cell receptor gene transfer","volume":"5","author":"Brusko","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2025.102685_bib24","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/ajt.12433","article-title":"Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation","volume":"13","author":"Putnam","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2025.102685_bib25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ajt.12629","article-title":"Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells","volume":"14","author":"Landwehr-Kenzel","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2025.102685_bib26","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1182\/blood-2013-03-492397","article-title":"Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease","volume":"122","author":"Veerapathran","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102685_bib28","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbmt.2017.07.009","article-title":"Clinical-grade-expanded regulatory T cells prevent graft-versus-Host disease while allowing a powerful T cell-dependent graft-versus-leukemia effect in murine models","volume":"23","author":"Del Papa","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.coi.2025.102685_bib29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2014-10-603449","article-title":"Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo","volume":"125","author":"Parmar","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib30","doi-asserted-by":"crossref","first-page":"35611","DOI":"10.18632\/oncotarget.26242","article-title":"Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution","volume":"9","author":"Kellner","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.coi.2025.102685_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00152","article-title":"Generation and function of induced regulatory T cells","volume":"4","author":"Schmitt","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib32","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/bloodadvances.2020003219","article-title":"First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings","volume":"5","author":"MacMillan","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2025.102685_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajt.2023.04.017","article-title":"Induced regulatory T cells modified by knocking down T-bet in combination with ectopic expression of inhibitory cytokines effectively protect graft-versus-host disease","volume":"23","author":"Gao","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2025.102685_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00375","article-title":"Large-scale generation of human allospecific induced Tregs with functional stability for use in immunotherapy in transplantation","volume":"11","author":"Alvarez-Salazar","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib35","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3324\/haematol.2010.025825","article-title":"Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy","volume":"95","author":"Bacchetta","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2025.102685_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T Cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib37","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.ymthe.2017.06.029","article-title":"IL-10-engineered human CD4","volume":"25","author":"Locafaro","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2025.102685_bib38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib39","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib40","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib42","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2025.102685_bib43","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","article-title":"In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127244","article-title":"Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients","volume":"4","author":"Meyer","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2025.102685_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","article-title":"Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2025.102685_sbref46","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.2024026446","article-title":"Donor regulatory T-cell therapy to prevent graft-versus-host disease","volume":"145","author":"Meyer","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139991","article-title":"Selective expansion of regulatory T cells using an orthogonal IL-2\/IL-2 receptor system facilitates transplantation tolerance","volume":"131","author":"Hirai","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102685_sbref48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.2022018440","article-title":"Prevention of acute GVHD using an orthogonal IL-2\/IL-2R\u03b2 system to selectively expand regulatory T cells in vivo","volume":"141","author":"Ramos","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102685_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136185","article-title":"CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD","volume":"5","author":"Imura","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2025.102685_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160674","article-title":"Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses","volume":"7","author":"Bolivar-Wagers","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2025.102685_bib51","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1172\/JCI135754","article-title":"Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease","volume":"130","author":"Shrestha","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102685_bib52","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102685_sbref53","article-title":"Human OX40L-CAR-T","volume":"16","author":"Rui","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102685_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1214","article-title":"Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses","volume":"9","author":"Sato","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.coi.2025.102685_sbref55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.stem.2024.05.004","article-title":"Human iPSC-derived CD4","volume":"31","author":"Yano","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coi.2025.102685_bib56","doi-asserted-by":"crossref","first-page":"1415102","DOI":"10.3389\/fimmu.2024.1415102","article-title":"CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102685_bib57","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/bloodadvances.2019000411","article-title":"Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice","volume":"3","author":"B\u00e9zie","year":"2019","journal-title":"Blood Adv"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279152500161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279152500161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:02:34Z","timestamp":1780635754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095279152500161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S095279152500161X"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102685","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cell approaches for graft-versus-host disease prevention","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102685"}}